Recombinant saccharomyces cerevisiae for synthesizing p-coumaric acid by using acetic acid as well as preparation method and application of recombinant saccharomyces cerevisiae

By constructing a recombinant Saccharomyces cerevisiae, overexpressing a specific enzyme system and integrating it into the genomic site, the inhibition problem when acetic acid is used as a carbon source was solved, efficient synthesis of p-coumaric acid was achieved, and the strain's acetic acid tolerance and yield were improved.

CN120775714APending Publication Date: 2025-10-14SOUTH CHINA UNIV OF TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510928912.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-07-07
Publication Date
2025-10-14

AI Technical Summary

Technical Problem

In the existing technology, plant extraction and chemical synthesis of p-coumaric acid have high energy consumption, low efficiency and are environmentally unfriendly, while research on microbial synthesis of p-coumaric acid has not been fully developed. Acetic acid has an inhibitory effect on cell growth when used as a carbon source, limiting its application in the synthesis of high-value-added products.

Method used

By constructing a recombinant Saccharomyces cerevisiae, overexpressing tyrosine lyase FjTAL, phenylalanine lyase AtPAL2, cinnamate 4-hydroxylase AtC4H, cytochrome P450 reductase AtATR2 and cytochrome B5 CYB5, and integrating them into specific sites of the yeast genome, the strain synthesizes p-coumaric acid using acetate as the sole carbon source. The Crispr-Cas9 gene editing and acclimation culture technology were used to improve the strain's acetic acid tolerance.

Benefits of technology

The recombinant Saccharomyces cerevisiae was able to grow well in a high-concentration acetic acid environment and efficiently synthesize p-coumaric acid using acetic acid as the sole carbon source, thereby improving yield and cell growth performance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120775714A_ABST
    Figure CN120775714A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of microbial metabolic engineering, and discloses recombinant saccharomyces cerevisiae for synthesizing p-coumaric acid by using acetic acid as well as a preparation method and application of the recombinant saccharomyces cerevisiae. The recombinant saccharomyces cerevisiae has the following characteristics that: tyrosine lyase FjTAL, phenylalanine lyase AtPAL2, cinnamic acid 4-hydroxylase AtC4H, cytochrome P450 reductase AtATR2 and cytochrome B5 CYB5 are subjected to overexpression. The invention also provides a construction method and a domestication method of the recombinant saccharomyces cerevisiae. Compared with recombinant saccharomyces cerevisiae which is not evolved, the recombinant saccharomyces cerevisiae evolved adaptively can well grow in a culture medium which takes acetic acid as a unique carbon source, and p-coumaric acid with higher yield can be synthesized. The invention provides a feasible strategy for synthesizing p-coumaric acid, flavonoid or stilbene natural products by using acetic acid as a carbon source.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of microbial metabolic engineering, and particularly relates to a recombinant brewer's yeast for synthesizing p-coumaric acid from acetic acid, and a preparation method and application thereof. Background Art

[0002] p-Coumaric acid ( p p-Coumaric acid (p-Coumaric acid) is a natural phenolic compound widely found in plants. It possesses numerous biological activities, including antioxidant, antibacterial, anti-inflammatory, lipid-lowering, and cancer and cardiovascular disease prevention. It is widely used in the food, pharmaceutical, and cosmetic industries. p-Coumaric acid is also a precursor to many high-value-added natural products, such as caffeic acid, naringenin, resveratrol, anthocyanins, and other flavonoid and stilbene natural products. Plants synthesize p-Coumaric acid via two distinct pathways. One pathway uses tyrosine as a substrate, where tyrosine lyase (TAL) directly deaminates tyrosine to form p-Coumaric acid. The other pathway involves the conversion of phenylalanine to cinnamic acid catalyzed by phenylalanine ammonia lyase (PAL). Cinnamic acid is then converted to p-Coumaric acid by cinnamic acid 4-hydroxylase (C4H4). At present, the main sources of p-coumaric acid are plant extraction, chemical synthesis and biosynthesis. Both plant extraction and chemical synthesis face problems such as high energy consumption, low efficiency and easy damage to the environment. Microbial synthesis of natural products such as p-coumaric acid has attracted widespread attention due to its advantages such as low cost, high yield and green environmental protection.

[0003] Acetate, also known as acetic acid, has abundant and diverse sources, including cellulose hydrolysis, industrial waste, and as a major byproduct of high-density microbial fermentation. Furthermore, carbon monoxide, methane, and carbon dioxide can be electrocatalyzed to produce acetic acid. Furthermore, the carbon sources currently used in microbial industrial fermentation are primarily based on food raw materials such as starch, sucrose, and glucose. Given the current global food shortage crisis and the "dual carbon" strategy, the use of green, renewable, non-food raw materials as alternative substrates for industrial microbial fermentation has attracted significant attention. As a green, renewable, and low-cost non-food carbon source, acetic acid holds great promise as a carbon source for microbial fermentation. Microorganisms also possess natural acetate metabolic pathways, where it can be further converted to acetyl-CoA via the acetate kinase-phosphotransacetylase (AckA-PTA) pathway or the acetyl-CoA synthetase (ACS) pathway, thereby entering central carbon metabolism to sustain cell growth and development. During microbial fermentation, acetic acid is typically added in the form of acetate. Because biomembranes are generally permeable to weak organic acids, acetate primarily enters cells as an undissociated molecule (HAc), entering the cell membrane's biphospholipid layer via free diffusion or active transport. This process can inhibit cell growth. Therefore, improving microbial tolerance to high concentrations of acetic acid is a prerequisite for synthesizing high-value-added products using acetate as a carbon source. Summary of the Invention

[0004] The primary purpose of the present invention is to overcome the shortcomings and deficiencies of the prior art and to provide a recombinant Saccharomyces cerevisiae that utilizes acetic acid to synthesize p-coumaric acid.

[0005] Another object of the present invention is to provide a method for preparing the recombinant Saccharomyces cerevisiae that utilizes acetic acid to synthesize p-coumaric acid.

[0006] Another object of the present invention is to provide the use of the recombinant Saccharomyces cerevisiae that utilizes acetic acid to synthesize p-coumaric acid.

[0007] The purpose of the present invention is achieved through the following technical solutions: A recombinant cerevisiae yeast for synthesizing p-coumaric acid using acetic acid has the following characteristics: overexpression of tyrosine lyase FjTAL, phenylalanine lyase AtPAL2, cinnamate 4-hydroxylase AtC4H, cytochrome P450 reductase AtATR2, and cytochrome B5 CYB5.

[0008] The amino acid sequence of the tyrosine lyase FjTAL is shown in Genbank KR095306.1.

[0009] The amino acid sequence of the phenylalanine lyase AtPAL2 is shown in Genbank NP_190894.1.

[0010] The amino acid sequence of the said cinnamic acid 4-hydroxylase AtC4H is shown in Genbank P92994.1.

[0011] The amino acid sequence of the said cytochrome P450 reductase AtATR2 is shown in X66017.1.

[0012] The amino acid sequence of the said cytochrome B5 protein CYB5 is shown in NP_014288.3.

[0013] The said tyrosine lyase FjTAL is preferably integrated at the gla80 locus of the genome.

[0014] The sequence of the coding nucleic acid of the said tyrosine lyase FjTAL is preferably shown in SEQ ID NO. 1.

[0015] The said phenylalanine lyase AtPAL2 and the said cinnamic acid 4-hydroxylase AtC4H are preferably integrated at the CAN1 locus of the genome.

[0016] The sequence of the coding nucleic acid of the said phenylalanine lyase AtPAL2 is preferably shown in SEQ ID NO. 2.

[0017] The sequence of the coding nucleic acid of the said cinnamic acid 4-hydroxylase AtC4H is preferably shown in SEQ ID NO. 3.

[0018] The said cytochrome P450 reductase AtATR2 and the said cytochrome B5 CYB5 are preferably integrated at the IX-1 locus of the genome.

[0019] The sequence of the coding nucleic acid of the said cytochrome P450 reductase AtATR2 is preferably shown in SEQ ID NO. 4.

[0020] The sequence of the coding nucleic acid of the said cytochrome B5 protein CYB5 is preferably shown in SEQ ID NO. 5.

[0021] The said recombinant Saccharomyces cerevisiae chassis strain is preferably a CEN.PK series strain; more preferably Saccharomyces cerevisiae CEN.PK2-1C.

[0022] The preparation method of the said recombinant Saccharomyces cerevisiae for synthesizing p-coumaric acid from acetic acid comprises the following steps: (1) integrating the tyrosine lyase FjTAL coding gene into the gla80 locus of the Saccharomyces cerevisiae chassis strain to obtain the SC2 strain; (2) integrating the phenylalanine lyase AtPAL2 coding gene and the cinnamic acid 4-hydroxylase AtC4H coding gene into the CAN1 locus of the SC2 strain to obtain the SC3 strain; (3) Integrating cytochrome P450 reductase AtATR2 encoding gene and cytochrome B5 protein CYB5 encoding gene into IX-1 site of SC3 strain to obtain SC4 strain, which is recombinant Saccharomyces cerevisiae for synthesizing p-coumaric acid from acetic acid; (4) Domesticating and culturing SC4 strain obtained in step (3) in acetic acid-containing medium to obtain recombinant Saccharomyces cerevisiae capable of synthesizing p-coumaric acid from acetic acid as the sole carbon source.

[0023] The integration method in steps (1), (2) and (3) is preferably a gene editing method; more preferably a Crispr-Cas9 gene editing method.

[0024] The DNA sequence of sg RNA targeting gla80 site used in the integration is as follows: cgccatactgcaactatcgt.

[0025] The DNA sequence of sg RNA targeting CAN1 site used in the integration is as follows: ggtataatatctaaggataa.

[0026] The DNA sequence of sg RNA targeting IX-1 site used in the integration is as follows: atcttaaatgaaagacagag.

[0027] The carbon source in the acetic acid-containing medium in step (4) is glucose 0-10 g / L and acetic acid 20-25 g / L; wherein the initial concentration of glucose is 10 g / L and the initial concentration of acetic acid is 20 g / L; during the domestication process, the concentration of glucose is gradually reduced to 0 and the concentration of acetic acid is gradually increased to 25 g / L.

[0028] The specific steps of the domestication culture are preferably as follows: 1) Streaking SC4 strain on YPD plate, selecting clones with better growth, inoculating in YPD medium and culturing to logarithmic growth phase or plateau phase to obtain seed liquid; 2) Inoculating the seed liquid obtained in step 1) in domestication medium and culturing for 18-24 h for subculture domestication; for each subculture, the concentration of acetic acid in the domestication medium used is unchanged and the concentration of glucose is reduced by 1 g / L until the concentration of glucose in the domestication medium is 1 g / L; the composition of the domestication medium used for the first time is as follows: acetic acid 20 g / L, glucose 10 g / L, tryptone 20 g / L and yeast extract 10 g / L, and the solvent is water; 3) Then domesticating in domestication medium containing acetic acid 20 g / L, glucose 1 g / L, tryptone 20 g / L and yeast extract 10 g / L for 2-4 generations; 4) Then domesticating 2-4 generations in domestication medium containing acetic acid 20 g / L, tryptone 20 g / L and yeast powder 10 g / L; 5) Then domesticating in domestication medium with gradually increasing acetic acid concentration, and domesticating 1-3 generations each time the acetic acid concentration is adjusted, until the acetic acid concentration is 25 g / L, to obtain recombinant Saccharomyces cerevisiae for synthesizing p-coumaric acid from acetic acid; in this step, acetic acid is the only carbon source in the domestication medium, and the concentration is increased from 20 g / L to 25 g / L, and the nitrogen source is tryptone 20 g / L and yeast powder 10 g / L.

[0029] The culture time in step 1) is preferably 16-20 h.

[0030] The inoculation amount of the seed liquid in step 2) is preferably OD 600 0.1-0.3 when inoculated into the domestication medium; more preferably 0.2.

[0031] The culture time of each generation in the subculture in step 2) is 20-24 h; more preferably 20 h.

[0032] The number of generations of domestication in steps 3) and 4) is preferably 3 generations.

[0033] The acetic acid concentration in the domestication culture in step 5) is increased by 0.5 g / L.

[0034] The number of generations of domestication culture in step 5) is preferably 2 generations.

[0035] A recombinant Saccharomyces cerevisiae capable of synthesizing p-coumaric acid from acetic acid as the only carbon source is obtained by the above preparation method.

[0036] The above recombinant Saccharomyces cerevisiae for synthesizing p-coumaric acid from acetic acid or the recombinant Saccharomyces cerevisiae capable of synthesizing p-coumaric acid from acetic acid as the only carbon source is applied to the synthesis of p-coumaric acid, flavonoids or stilbene natural products from acetic acid as the carbon source.

[0037] The present application has the following advantages and effects relative to the prior art: (1) The recombinant engineering bacteria provided by the present application can tolerate a higher concentration of acetic acid and grow well at a high acetic acid concentration.

[0038] (2) The recombinant engineering bacteria provided by the present application can synthesize p-coumaric acid from acetic acid as the only carbon source, and have a higher OD 600 value and a higher p-coumaric acid accumulation amount compared with unevolved strains. BRIEF DESCRIPTION OF DRAWINGS

[0039] Figure 1is the construction map of plasmid pY26-INO1p-FjTAL-CYC1t.

[0040] Figure 2 is the construction map of plasmid pY-26(CYC1t-AtC4H-GAL10p)+(GAL1p-AtPAL2-CIT2t).

[0041] Figure 3 is the construction map of plasmid pY26-(SDH1t-AtATR2-TDH3p)+(SED1p-CYB5-PDB1t).

[0042] Figure 4 is the growth state map of each generation of evolution strains in different concentrations of glucose and acetic acid medium in the laboratory evolution process.

[0043] Figure 5 is the culture schematic diagram of EVO(1,2,3)-35 parallel evolution strains streaked on the plate containing 20 g / L acetic acid as carbon source and the OD 600 detection result map.

[0044] Figure 6 is the OD 600 value and the detection result map of coumaric acid yield of unevolved control group SC4 and 15 single clones selected after evolution. DETAILED DESCRIPTION

[0045] The application will be described in further detail below with reference to the embodiments and drawings, but the embodiments of the application are not limited thereto.

[0046] The amino acid sequence of tyrosine lyase FjTAL is shown in Genbank KR095306.1, the amino acid sequence of phenylalanine lyase AtPAL2 is shown in Genbank NP_190894.1, the amino acid sequence of cinnamic acid 4-hydroxylase AtC4H is shown in Genbank P92994.1, the amino acid sequence of cytochrome P450 reductase AtATR2 is shown in X66017.1, and the amino acid sequence of cytochrome B5 protein CYB5 is shown in NP_014288.3. The codon optimization of these proteins is completed by the online tool GenSmart Optimization (Jin Siree Biological Technology Co., Ltd.), and the gene synthesis is completed by Shanghai Shengong (Shengong Biological Engineering (Shanghai) Co., Ltd.).

[0047] Gibson assembly method, the specific operation is according to the operation instruction of Shanghai Biosciences Ready-to-Use Seamless Cloning Kit (NO. B632219).

[0048] Yeast strain gene editing: if no special instructions, use Frozen-EZ Yeast Transformation II™ kit (purchased from ZYMO RESEARCH company in the United States) according to the product instruction to transform.

[0049] PCR amplification includes conventional denaturation, annealing and extension steps; wherein the annealing temperature is according to the recommended temperature when designing the primer, generally 56 ℃, and the extension time of the fragment is according to the instruction of the used enzyme.

[0050] Determination of p-coumaric acid accumulation: take equal volume of fermentation broth and HPLC grade methanol in a broken tube. Use Bioprep-24R homogenizer to extract, then centrifuge at 12000 g for 10 minutes. The supernatant is filtered through a 0.22 μm filter for high performance liquid chromatography analysis, using LC-16 (Shimadzu Corporation, Japan) equipped with SPD-16 dual wavelength ultraviolet detector, using C18 chromatographic column (250 × 4.6 mm 5 um). Gradient elution, A phase 0.1% (v / v) formic acid aqueous solution, C phase acetonitrile, elution condition: 0-10 min 10-40% C, 10-20 min 40-60% C, 20-23 min 60% C, 23-25 min 60-10% C, 25-28 min 10% C, flow rate is 1 mL / min, injection volume is 10 μL, detection wavelength is 285 nm.

[0051] The primer used in the application is shown in Table 1: Table 1

[0052] Example 1: Construction of p-coumaric acid synthesis pathway with tyrosine as substrate in Saccharomyces cerevisiae The FjTAL gene with nucleotide sequence as shown in SEQ ID NO. 1 was synthesized by a company, and a FjTAL gene fragment was obtained by amplification with primers FjTAL-1F and FjTAL-1R. The plasmid framework was amplified with primers pY26-1F and pY26-1R using pY26-GPD-TEF (also named as pY26TEF-GPD, obtained from BioVector NTCC Plasmid Bank) as a template, and the product was recovered. Then, the FjTAL gene fragment and the pY26-GPD-TEF plasmid framework were constructed into a plasmid using Gibson assembly technology to obtain the pY26-TEF1p-FjTAL-ADH1t (abbreviated as pY26-FjTAL) plasmid, as shown in Figure 1 .

[0053] The pYZ463 (obtained from the addgene global plasmid sharing platform) was amplified with primers FjTALsg-F and FjTALsg-R, and then transformed into E. coli DH5a, extracted for plasmid and verified by sequencing to finally obtain the sgRNA DNA of Crispr-Cas9 plasmid with cgccatactgcaactatcgt as the sgRNA DNA, which is pYZ463-FjTAL targeting the gla80 site. The TEF1p-FjTAL-ADH1t expression cassette was amplified with primers FjTAL-2F and FjTAL-2R using the plasmid pY26-FjTAL as a template, and the FjTAL site donor (Donor) DNA was obtained after purification. The Frozen-EZ yeast transformation kit was used to transform 1 μg of pYZ463-FjTAL plasmid and 1 μg of FjTAL site Donor DNA into Saccharomyces cerevisiae CEN.PK2-1C (purchased from Shanghai Yuanzu Biotechnology Co., Ltd., also referred to as SC1 strain in this experiment) to complete the integration of the FjTAL gene, and the strain was named as SC2.

[0054] Example 2: Construction of p-coumaric acid synthesis pathway using phenylalanine as substrate in Saccharomyces cerevisiae The AtPAL2 gene and the AtC4H gene with nucleotide sequences as shown in SEQ ID NO. 2 and SEQ ID NO. 3 were synthesized by a company, and the two genes were amplified by using primers AtPAL2-F / AtPAL2-R and AtC4H-F / AtC4H-R, respectively, to obtain the AtPAL2 gene fragment and the AtC4H gene fragment. The GAL1,10-F / GAL1,10-R primers were used to amplify the double promoter GAL1,10 from the pESC-Ura (purchased from New England Biolabs Technology Co., Ltd.) plasmid as a template to obtain the GAL1,10 fragment; and the pESC-1F and pESC-1R primers were used to amplify the pESC-Ura plasmid to obtain the pESC-Ura-1 framework. After the products were recovered, the Gibson assembly technology was used to construct a plasmid from the AtPAL2 gene fragment, the AtC4H gene fragment, the GAL1,10 fragment and the pESC-Ura-1 framework to obtain the pESC-Ura (GAL1p-AtPAL2-CYC1t) + (GAL10p-AtC4H-ADH1t) (abbreviated as pESC-AtPAL2-AtC4H) plasmid, as shown in Figure 2 .

[0055] The pYZ463 was amplified by using primers AtPAL2-AtC4Hsg-F and AtPAL2-AtC4Hsg-R, and then transformed into E. coli DH5α, extracted and verified by sequencing to finally obtain the Crispr-Cas9 plasmid with ggtataatatctaaggataa as the sgRNA DNA, which was pYZ463-AtPAL2-AtC4H targeting the CAN1 site. The primers AtPAL2-AtC4H-F and AtPAL2-AtC4H-R were used to amplify the AtPAL2 gene expression cassette and the AtC4H gene expression cassette from the plasmid pESC-AtPAL2-AtC4H as a template, and the purified AtPAL2-AtC4H site donor (Donor) DNA was obtained. The Frozen-EZ yeast transformation kit was used to transform 1 μg of pYZ463-AtPAL2-AtC4H plasmid and 1 μg of AtPAL2-AtC4H site Donor DNA into the S. cerevisiae SC2 strain to complete the integration of the AtPAL2-AtC4H gene, and the strain was named as SC3.

[0056] The AtATR2 gene (nucleotide sequence shown in SEQ ID NO. 4) and the CYB5 gene (nucleotide sequence shown in SEQ ID NO. 5) were synthesized by the company and amplified using primers AtATR2-F / AtATR2-R and CYB5-F / CYB5-R, respectively, to obtain the AtATR2 gene fragment and the CYB5 gene fragment. Using Saccharomyces cerevisiae CEN.PK2-1C as a template, the SED1p promoter (nucleotide sequence shown in SEQ ID NO. 6) and the TDH3p promoter (nucleotide sequence shown in SEQ ID NO. 7) were amplified using primers SED-F / SED-R and TDH-F / TDH-R, respectively, to obtain the SED1p promoter gene fragment and the TDH3p promoter fragment. Using the pESC-Ura plasmid as a template, the pESC-2F and pESC-2R primers were used to amplify the pESC-Ura plasmid to obtain the pESC-Ura-2 framework. After the product was recovered, the AtATR2 gene fragment, CYB5 gene fragment, SED1p fragment, TDH3p fragment and pESC-Ura-2 framework were assembled into a plasmid using Gibson assembly technology to obtain the pESC-Ura (TDH3p-AtATR2-ADH1t) + (SED1p-CYB5-CYCt) (abbreviated as pESC-AtATR2-CYB5) plasmid, as shown in Figure 5. Figure 3 shown.

[0057] pYZ463 was amplified using primers AtATR2-CYB5sg-F and AtATR2-CYB5sg-R. Escherichia coli DH5α was then transformed, the plasmid was extracted, and sequencing was performed to obtain the Crispr-Cas9 plasmid pYZ463-AtATR2-CYB5, which targets the IX-1 locus and carries the sgRNA DNA atcttaaatgaaagacagag. Primers AtATR2-CYB5-F and AtATR2-CYB5-R were used to amplify the AtATR2 and CYB5 gene expression cassettes using the plasmid pESC-AtATR2-CYB5 as a template. The AtATR2-CYB5 locus donor DNA was purified. Using the Frozen-EZ yeast transformation kit, 1 μg of pYZ463-AtATR2-CYB5 plasmid and 1 μg of AtATR2-CYB5 locus Donor DNA were transformed into the Saccharomyces cerevisiae SC3 strain to complete the integration of the AtATR2-CYB5 gene. The resulting strain was named SC4.

[0058] Example 3: Laboratory adaptive evolution to obtain a high-concentration acetic acid-tolerant Saccharomyces cerevisiae strain SC4 strain was streaked on YPD plate, incubated in 30℃ incubator for 48h, and one single colony with good growth was selected and inoculated in YPD liquid medium for 16-18h. The obtained culture was transferred into a medium containing 20g / L acetic acid, 10g / L glucose, 20g / L tryptone and 10g / L yeast extract (solvent: deionized water) with an initial OD 600 value of 0.2, 3 parallels, and acclimation culture was started, and named as EVO1-1, EVO2-1, EVO3-1, respectively. The acclimation time of each generation was about 20h, and the acclimation condition was 30℃, 220rpm.

[0059] After EVO(1,2,3)-1 was acclimated for 20h, it was transferred into a new medium containing 20g / L acetic acid, 9g / L glucose, 20g / L tryptone and 10g / L yeast extract, with an initial OD 600 value of 0.2, and acclimation culture was started, and named as EVO(1,2,3)-2. The repeated transfer and acclimation was performed, and the acetic acid concentration in the medium was unchanged, and the glucose concentration was reduced by 1g / L per generation, until EVO(1,2,3)-10, the composition of the medium was as follows: 20g / L acetic acid, 1g / L glucose, 20g / L tryptone and 10g / L yeast extract. EVO(1,2,3)-10 was cultured to the logarithmic growth phase or the stationary phase, and was transferred into a new medium containing 20g / L acetic acid, 1g / L glucose, 20g / L tryptone and 10g / L yeast extract with an initial OD 600 value of 0.2, and the repeated operation was performed, and the concentration of the newly added medium was kept unchanged, and acclimation was performed for 2 generations, and named as EVO(1,2,3)-12. When the OD 600 of EVO(1,2,3)-12 was 1, it was transferred into a new medium containing 20g / L acetic acid, 1g / L glucose, 20g / L tryptone and 10g / L yeast extract with an initial OD 600 value of 0.2, and acclimation culture was started, and named as EVO(1,2,3)-15. In the subsequent transfer and acclimation, the acetic acid concentration in the medium was increased by 0.5g / L every two generations, until the acetic acid concentration in the medium was 25g / L at the 35th generation, and named as EVO(1,2,3)-35. The growth amount of the strains of different generations and the acetic acid and glucose concentrations in the medium are shown in Table 1, and it can be seen that with the increase of the evolution generation, the OD 600 value of the evolution strain gradually increased in the medium with acetic acid as the sole carbon source, indicating that the evolution strain could utilize acetic acid for growth. Figure 4

[0060] Example 4: Screening of Saccharomyces cerevisiae strain resistant to high-concentration acetic acid and high-p- coumaric acid-producing strain​ EVO1-35, EVO2-35, and EVO3-35 were streaked onto plates containing 20 g / L acetic acid as a carbon source and incubated in an inverted incubator at 30°C for 72 h. Approximately 50 single clones of EVO(1,2,3)-35 were picked from each plate and fermented in 20 g / L acetic acid medium for 72 h. The top 5 OD values ​​of each evolution group were screened. 600 Monoclonal with high value ( Figure 5 ).

[0061] The 15 selected monoclonal clones were streaked on 20 g / L acetic acid plates, and the seed solution was shaken after the monoclonal clones grew out. The initial OD 600 The value was 0.2, and the cells were transferred to a medium containing 20 g / L acetic acid as carbon source and fermented for 72 h. The OD 600 value and p-coumaric acid yield, and screen out OD 600 The monoclonal evolved strain with high acetic acid value and high p-coumaric acid accumulation is a recombinant Saccharomyces cerevisiae that can synthesize p-coumaric acid using acetic acid ( Figure 6 ).

[0062] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be considered as equivalent replacement methods and are included in the scope of protection of the present invention.

Claims

1. A recombinant Saccharomyces cerevisiae that utilizes acetic acid to synthesize p-coumaric acid, characterized in that The invention has the following characteristics: overexpression of tyrosine lyase FjTAL, phenylalanine lyase AtPAL2, cinnamate 4-hydroxylase AtC4H, cytochrome P450 reductase AtATR2, and cytochrome B5 CYB5.

2. The recombinant Saccharomyces cerevisiae for synthesizing p-coumaric acid using acetic acid according to claim 1, wherein: The amino acid sequence of the tyrosine lyase FjTAL is shown in Genbank KR095306.1; The amino acid sequence of the phenylalanine lyase AtPAL2 is shown in Genbank NP_190894.1; The amino acid sequence of the cinnamate 4-hydroxylase AtC4H is shown in Genbank P92994.1; The amino acid sequence of the cytochrome P450 reductase AtATR2 is shown in X66017.1; The amino acid sequence of the cytochrome B5 protein CYB5 is shown in NP_014288.

3.

3. The recombinant Saccharomyces cerevisiae for synthesizing p-coumaric acid using acetic acid according to claim 2, characterized in that: The sequence of the nucleic acid encoding the tyrosine lyase FjTAL is shown in SEQ ID NO.1; The sequence of the nucleic acid encoding the phenylalanine lyase AtPAL2 is shown in SEQ ID NO.2; The sequence of the nucleic acid encoding cinnamate 4-hydroxylase AtC4H is shown in SEQ ID NO.3; The sequence of the nucleic acid encoding the cytochrome P450 reductase AtATR2 is shown in SEQ ID NO.4; The sequence of the nucleic acid encoding the cytochrome B5 protein CYB5 is shown in SEQ ID NO.5; The tyrosine lyase FjTAL is integrated into the genome at the gla80 site; The phenylalanine lyase AtPAL2 and the cinnamate 4-hydroxylase AtC4H are integrated into the genome CAN1 site; The cytochrome P450 reductase AtATR2 and the cytochrome B5 CYB5 are integrated into the genome IX-1 site.

4. The method for preparing a recombinant Saccharomyces cerevisiae for synthesizing p-coumaric acid using acetic acid according to any one of claims 1 to 3, characterized in that The steps include: (1) The gene encoding the tyrosine lyase FjTAL was integrated into the gla80 site of the Saccharomyces cerevisiae chassis strain to obtain the SC2 strain; (2) The phenylalanine lyase AtPAL2 gene and the cinnamate 4-hydroxylase AtC4H gene were integrated into the CAN1 locus of the SC2 strain to obtain the SC3 strain; (3) The gene encoding cytochrome P450 reductase AtATR2 and the gene encoding cytochrome B5 protein CYB5 were integrated into the IX-1 site of the SC3 strain to obtain the SC4 strain, which is a recombinant Saccharomyces cerevisiae that synthesizes p-coumaric acid from acetic acid; (4) The SC4 strain obtained in step (3) is acclimated and cultured in a culture medium containing acetic acid to obtain a recombinant Saccharomyces cerevisiae that can synthesize p-coumaric acid using acetic acid as the sole carbon source.

5. The method for preparing recombinant cerevisiae for synthesizing p-coumaric acid using acetic acid according to claim 4, characterized in that The integrated method described in step (1), step (2) and step (3) is a gene editing method; The DNA sequence of the sg RNA used in the integration targeting the gla80 site is as follows: cgccatactgcaactatcgt; The DNA sequence of the sg RNA used in the integration targeting the CAN1 site is as follows: ggtataatatctaaggataa; The DNA sequence of the sg RNA used in the integration targeting the IX-1 site is as follows: atcttaaatgaaagacagag.

6. The preparation method according to claim 4, characterized in that: The carbon source in the acetic acid-containing culture medium in step (4) is 0-10 g / L glucose and 20-25 g / L acetic acid; wherein the initial concentration of glucose is 10 g / L and the initial concentration of acetic acid is 20 g / L; during the acclimation process, the concentration of glucose is gradually reduced to 0, and the concentration of acetic acid is gradually increased to 25 g / L.

7. The preparation method according to claim 4, characterized in that: The specific steps of the domestication and cultivation are as follows: 1) Streak the SC4 strain on a YPD plate, select clones with good growth, inoculate them into YPD medium, and culture until the logarithmic growth phase or stationary phase to obtain seed solution; 2) inoculating the seed solution obtained in step 1) into an acclimation medium and culturing the seed solution for 18-24 hours before subculturing the seed solution for acclimation; with each subculturing, the acetic acid concentration in the acclimation medium remains unchanged, while the glucose concentration is reduced by 1 g / L until the glucose concentration in the acclimation medium reaches 1 g / L; the composition of the acclimation medium used for the first time is as follows: 20 g / L acetic acid, 10 g / L glucose, 20 g / L tryptone, and 10 g / L yeast extract, with water as the solvent; 3) Then, acclimate the cells for 2 to 4 generations in an acclimatization medium containing 20 g / L acetic acid, 1 g / L glucose, 20 g / L tryptone, and 10 g / L yeast extract. 4) Then, acclimate the cells for 2 to 4 generations in an acclimatization medium containing 20 g / L acetic acid, 20 g / L tryptone, and 10 g / L yeast powder; 5) The yeast was then acclimated in an acclimation medium with gradually increasing acetic acid concentrations, with acclimation culture continued for one to three generations each time the acetic acid concentration was adjusted until the acetic acid concentration reached 25 g / L, thereby obtaining a recombinant Saccharomyces cerevisiae capable of synthesizing p-coumaric acid from acetic acid. In this step, acetic acid was the sole carbon source in the acclimation medium, with the concentration increasing from 20 g / L to 25 g / L, and the nitrogen sources were 20 g / L tryptone and 10 g / L yeast extract.

8. The preparation method according to claim 7, characterized in that: The culture time in step 1) is 16 to 20 hours; The inoculation amount of the seed solution in step 2) is based on the OD 600 Calculated for 0.1 to 0.3; The culture time for each generation in the passage acclimation described in step 2) is 20 to 24 hours; The number of generations of acclimatization described in step 3) and step 4) is 3; The acetic acid concentration in the acclimation culture described in step 5) is increased by 0.5 g / L; The number of generations of acclimation culture described in step 5) is 2 generations.

9. A recombinant Saccharomyces cerevisiae capable of synthesizing p-coumaric acid using acetic acid as the sole carbon source, characterized in that: The method is obtained by the preparation method according to any one of claims 4 to 8.

10. Use of the recombinant Saccharomyces cerevisiae capable of synthesizing p-coumaric acid using acetic acid as the sole carbon source according to any one of claims 1 to 3 or the recombinant Saccharomyces cerevisiae capable of synthesizing p-coumaric acid using acetic acid as the sole carbon source according to claim 9 in synthesizing p-coumaric acid, flavonoids or stilbenes natural products using acetic acid as the carbon source.